These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18245476)

  • 1. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
    Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH
    Cancer Res; 2008 Feb; 68(3):759-66. PubMed ID: 18245476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 mutation in large cell carcinoma of the lung.
    Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
    Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
    Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA
    Nature; 2002 Sep; 419(6903):162-7. PubMed ID: 12226664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
    Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
    Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
    Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
    Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.
    Miyoshi H; Nakau M; Ishikawa TO; Seldin MF; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(8):2261-6. PubMed ID: 11956081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
    Peña CG; Nakada Y; Saatcioglu HD; Aloisio GM; Cuevas I; Zhang S; Miller DS; Lea JS; Wong KK; DeBerardinis RJ; Amelio AL; Brekken RA; Castrillon DH
    J Clin Invest; 2015 Nov; 125(11):4063-76. PubMed ID: 26413869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
    Wang ZJ; Churchman M; Campbell IG; Xu WH; Yan ZY; McCluggage WG; Foulkes WD; Tomlinson IP
    Br J Cancer; 1999 Apr; 80(1-2):70-2. PubMed ID: 10389980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
    Scott KD; Nath-Sain S; Agnew MD; Marignani PA
    Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
    Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
    Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of tumor suppression by LKB1.
    Vaahtomeri K; Mäkelä TP
    FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
    Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M
    Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
    Strazisar M; Mlakar V; Rott T; Glavac D
    Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
    Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
    Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
    Lian Z; De Luca P; Di Cristofano A
    J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy.
    Contreras CM; Akbay EA; Gallardo TD; Haynie JM; Sharma S; Tagao O; Bardeesy N; Takahashi M; Settleman J; Wong KK; Castrillon DH
    Dis Model Mech; 2010; 3(3-4):181-93. PubMed ID: 20142330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice.
    Nakau M; Miyoshi H; Seldin MF; Imamura M; Oshima M; Taketo MM
    Cancer Res; 2002 Aug; 62(16):4549-53. PubMed ID: 12183403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.